摘要
目的:比较头孢他啶与哌拉西林/他唑巴坦在治疗血液病合并感染中的疗效和安全性。方法:52例患者采用哌拉西林/他唑巴坦治疗,47例患者采用头孢他啶治疗。结果:两组总有效率和不良反应的差异均无统计学意义(P>0.05)。结论:两药均可作为免疫力低下患者合并感染的经验性治疗。
Objective:To compare the efficacy and safety of ceftazidime and piperacillin/tazobactam in the treatment of hemopathy with infections.Methods:Fifty two patients with hemopathy associated with infections were treated by piperacillin/tazobactam and forty seven patients were treated by ceftazidime.Results:There was no statistical significance of difference in the total efficiency and the rate of adverse reactions between the two groups(P > 0.05).Conclusion:The two kinds of medicine can be used empirically in the treatment of hemopathy with infections in patients with low immunity.
出处
《中国药业》
CAS
2005年第2期66-67,共2页
China Pharmaceuticals
